Category: Biopharma / Pharma

yellow pills

Repeat Deficiencies in Lupin Limited Warning Letters

When observations are identified during an inspection, it is FDA’s expectation that a firm will remediate the issues. This expectation is even more important if a firm receives a warning letter. Lupin Limited (India) seems to have come up short on both accounts.

Read More »
Most Popular Blog Posts - Larger Font 720

FDAzilla’s Top 20 Posts of All Time

Over the years, the FDAzilla blog has published over 650 articles. We hope this compilation will serve as a resource for you and your company.  It should also help orient you to the scope of the FDAzilla blog as you continue to follow our efforts to provide accessible FDA data and insights.

Read More »

Not Finding What You Are Looking For?

SEARCH OUR BLOG:

SEARCH OUR PRO KNOWLEDGE BASE:

CONTACT US:      844-332-3320 | info@fdazilla.com

Can’t find what you are looking for? Contact us.